KIMS - IntraDay Trade Analysis with Live Signals
Back to ListIntraDay Trade Rating: 3.6
| Stock Code | KIMS | Market Cap | 27,055 Cr. | Current Price | 677 ₹ | High / Low | 798 ₹ |
| Stock P/E | 96.6 | Book Value | 57.2 ₹ | Dividend Yield | 0.00 % | ROCE | 16.0 % |
| ROE | 14.0 % | Face Value | 2.00 ₹ | DMA 50 | 670 ₹ | DMA 200 | 665 ₹ |
| Chg in FII Hold | -0.70 % | Chg in DII Hold | 0.60 % | PAT Qtr | 72.5 Cr. | PAT Prev Qtr | 63.7 Cr. |
| RSI | 48.6 | MACD | -1.78 | Volume | 7,34,565 | Avg Vol 1Wk | 3,88,985 |
| Low price | 528 ₹ | High price | 798 ₹ | PEG Ratio | 322 | Debt to equity | 0.46 |
| 52w Index | 55.0 % | Qtr Profit Var | -5.23 % | EPS | 7.20 ₹ | Industry PE | 43.5 |
🔎 Analysis: KIMS shows weak-to-moderate potential for intraday trading today. RSI at 48.6 indicates neutral momentum, while MACD (-1.78) reflects mild bearish undertone. Price is hovering around both 50 DMA (670 ₹) and 200 DMA (665 ₹), suggesting consolidation. Current volume (7.3 lakh) is higher than weekly average (3.8 lakh), ensuring strong liquidity for intraday moves.
💰 Optimal Buy Price: Around 670–680 ₹ (near support zone).
📈 Profit Exit Levels: 690 ₹ (first resistance), 705 ₹ (secondary resistance).
📉 Stop-Loss: 660 ₹ (below intraday support).
⏳ If Already Holding: Consider exiting near 690–705 ₹ if momentum sustains with volume confirmation. If price fails to hold above 670 ₹, exit intraday to protect capital.
✅ Positive
- ROCE (16%) and ROE (14%) highlight operational efficiency.
- PAT growth from 63.7 Cr. to 72.5 Cr. sequentially shows earnings improvement.
- DII holding increased (+0.60%), reflecting domestic institutional support.
- Low debt-to-equity ratio (0.46) compared to sector peers.
⚠️ Limitation
- Stock P/E (96.6) is extremely high compared to industry PE (43.5), suggesting stretched valuation.
- PEG ratio (322) indicates severe valuation concerns relative to growth.
- Dividend yield is 0.00%, limiting income appeal.
- Price consolidation near DMA levels shows indecision in trend direction.
📉 Company Negative News
- FII holding decreased (-0.70%), showing reduced foreign investor confidence.
- Quarterly profit variation (-5.23%) indicates sequential decline.
📈 Company Positive News
- DII holding increased (+0.60%), reflecting domestic support.
- PAT improved sequentially, showing earnings growth despite valuation concerns.
🏭 Industry
- Industry PE (43.5) is much lower than KIMS’s PE (96.6), suggesting heavy premium valuation compared to peers.
- Healthcare sector remains strong, supported by rising demand and expansion trends.
🔮 Conclusion
KIMS is a weak-to-moderate intraday candidate today. Fundamentals show growth, but technicals remain weak with stretched valuations. Best approach: buy near 670–680 ₹, target 690–705 ₹, and keep a strict stop-loss at 660 ₹. If already holding, exit on resistance test or cut losses if price slips below support.
Would you like me to extend this into a peer benchmarking overlay against other hospital and healthcare service stocks, so you can see if KIMS’s premium valuation is justified by relative strength?